trans-2,3-Difluror-4-(4-propylcyclohexyl)butoxybenzene, 97%, 5g

Methyl 3-(azetidin-1-ylmethyl)benzoate, 98%, 100mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 100 ml, 90 mm, 1 Piece

4,5,6,7-Tetrahydrothieno[3,2-c]pyridine hydrochloride, 96.0%, 100g

(3aS,8aR)-2-(Pyrazin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 1g

4',5'-Bis(4-carboxyphenyl)-[1,1':2',1''-terphenyl]-4,4''-dicarboxylic acid, 97%, 1g

1,4-Diethynyl-2,5-dimethylbenzene>98.0%(GC)1g

N-[3-(trifluoromethyl)phenyl]guanidine, 95.0%, 1g

5-[(3S,4R)-1-[(tert-butoxy)carbonyl]-3-{[(tert-butyldimethylsilyl)oxy]methyl}piperidin-4-yl]-2-fluorobenzoic acid, 96%, 250mg

(3-Azabicyclo[3.1.0]hexan-6-yl)methanol, 98+%, 250mg

(2-Methyl-2H-indazol-4-yl)boronic acid, 95.0%, 500mg

(2R,3R)-2-Methylazetidin-3-ol hydrochloride, 98%, 10g

1-Fluoro-3-methoxy-5-methylbenzene, 95.0%, 100g